Lupus Foundation of America Announces LFA LIFT to Accelerate Development of New Lupus Treatments

Leading Lupus Researchers Recognized for Exceptional Work in the Field

Lupus Foundation of America Congratulates Aurinia Pharmaceuticals on FDA Approval of Lupkynis™ (voclosporin) to Treat Lupus Nephritis

Lupus Foundation of America Sees Big Win with FDA Approval of Benlysta® for Lupus Nephritis

Diana Gray to Lead 2021 National Health Council Board of Directors

Lupus Foundation of America to Present Findings on Self-Management Resource and Key Global Recommendations Addressing Major Challenges in Lupus at American College of Rheumatology Annual Meeting 

Lupus Foundation of America Launches Next-Generation, Patient-Powered Data Platform to Accelerate and Advance Lupus Research

Lupus Foundation of America and American Academy of Family Physicians Collaborate to Help Improve the Diagnosis and Management of Lupus

Lupus Foundation of America Awarded New Multi-Million Dollar Grant to Increase Lupus Awareness, and Expand Self-management Resources and Services

Walk to End Lupus Now® Goes Virtual, Unites Lupus Community From Coast to Coast

Early Career Scientists Receive Lupus Research Grants Supporting Critical Studies and Growth of Field

Study Supports Alternative Method for Estimating Treatment Effects in Clinical Trials